Bienaime Jean Jacques Insider Trades & Stock Holdings

Keros Therapeutics, Inc. · Latest filing Jun 15, 2026

Bienaime Jean Jacques at Keros Therapeutics, Inc. has 1 Form 4 trade on file since Jun 15, 2026. Open-market activity: 1 purchase ($10.19K) and 0 sales ($0), net +$10.19K. Latest filing: acquired 1K shares of $KROS on Jun 15, 2026 at $10.19.

Trades on file

1

Open-market bought

$10.19K

Open-market sold

$0

Net open-market

+$10.19K

Latest filing

Jun 15, 2026

All insider trades by Bienaime Jean Jacques

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$KROS	Buy (Open-market buy) 10b5-1	1K	$10.19	$10.19K			+7.2%	+7.7%				—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Bienaime Jean Jacques traded

• $KROS

Frequently asked questions

Has Bienaime Jean Jacques been buying or selling stock?

Bienaime Jean Jacques has 1 open-market purchase and 0 open-market sales on file, net +$10.19K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Bienaime Jean Jacques's latest insider trade?

acquired 1K shares of $KROS on Jun 15, 2026 at $10.19.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.